Sandra Torregrosa-Allen
Overview
Explore the profile of Sandra Torregrosa-Allen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Dayal N, Reznickova E, Hernandez D, Perina M, Torregrosa-Allen S, Elzey B, et al.
J Med Chem
. 2021 Jul;
64(15):10981-10996.
PMID: 34288692
The 3-pyrazolo[4,3-]quinoline moiety has been recently shown to be a privileged kinase inhibitor core with potent activities against acute myeloid leukemia (AML) cell lines in vitro. Herein, various 3-pyrazolo[4,3-]quinoline-containing compounds...
12.
Collins C, Mondjinou Y, Loren B, Torregrosa-Allen S, Simmons C, Elzey B, et al.
Biomacromolecules
. 2016 Jul;
17(9):2777-86.
PMID: 27387820
Polyrotaxanes, a family of rod-shaped nanomaterials comprised of noncovalent polymer/macrocycle assemblies, are being used in a growing number of materials and biomedical applications. Their physiochemical properties can vary widely as...
13.
Sun B, Taha M, Ramsey B, Torregrosa-Allen S, Elzey B, Yeo Y
J Control Release
. 2016 May;
235:91-98.
PMID: 27238443
Intraperitoneal (IP) chemotherapy is a promising post-surgical therapy of ovarian cancer, but the full potential is yet to be realized. To facilitate IP chemotherapy of ovarian cancer, we developed an...
14.
Cho E, Sun B, Doh K, Wilson E, Torregrosa-Allen S, Elzey B, et al.
Biomaterials
. 2014 Dec;
37:312-9.
PMID: 25453960
Intraperitoneal (IP) chemotherapy is a promising post-surgical therapy of solid carcinomas confined within the peritoneal cavity, with potential benefits in locoregional and systemic management of residual tumors. In this study,...
15.
Mehtala J, Torregrosa-Allen S, Elzey B, Jeon M, Kim C, Wei A
Nanomedicine (Lond)
. 2014 Feb;
9(13):1939-55.
PMID: 24498890
Aim: The synergistic effects of gold nanorod (GNR)-mediated mild hyperthermia (MHT; 42-43°C) and cisplatin (CP) activity was evaluated against chemoresistant SKOV3 cells in vitro and with a tumor xenograft model....